We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma

This study has been terminated.
(Initial Principal Investigator left Moffitt)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00361088
First Posted: August 7, 2006
Last Update Posted: November 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Millennium Pharmaceuticals, Inc.
National Cancer Institute (NCI)
Information provided by:
H. Lee Moffitt Cancer Center and Research Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)